INVA
Innoviva, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.08
+1.44%Forward multiples
Based on analyst estimates
- P/E forward
- 9.64x
- P/E 2026E
- 8.74x
- P/E 2027E
- 9.35x
- P/E 2028E
- 10.74x
- P/S forward
- 3.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.33x
- PEG TTM
- 0.34x
- Price / book
- 1.23x
- Price / sales
- 3.43x
- Price / cash flow
- 7.95x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.74x
- EV / EBITDA
- 1.58x
- EV / EBIT
- 7.46x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026